Search - Prime Therapeutics
-
publications High-Cost Therapy Profile: February 2025 Revakinagene taroretcel Ocular implant | Neurotech Pharmaceuticals, Inc. Ophthalmology February 13, 2025 Proposed indications Macular...
-
publications 2024 Employer Market Insights Report June 28, 2024 Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication,...
-
Cover image for FDA Decisions Expected_February 2025 Drug pipeline for February 2025 Prime Therapeutics /fda-decisions-expected-february-2025 About Prime Therapeutics Prime Therapeutics logo Prime...
Prime Article: Research & Publications PA Research & Publications: FDA Decisions Expected -
Publications High Cost Therapy Profile: October 2024 Eladocagene Exuparvovec October 15, 2024 Neurology Eladocagene Exuparvovec Intrapuraminal PTC Therapeutics, Inc. Proposed indications...